Edwards Lifesciences Statistics

Total Valuation

BVMF:E1WL34 has a market cap or net worth of BRL 237.29 billion. The enterprise value is 219.65 billion.

Market Cap	237.29B
Enterprise Value	219.65B

Important Dates

The last earnings date was Thursday, April 23, 2026.

Earnings Date	Apr 23, 2026
Ex-Dividend Date	n/a

Share Statistics

Current Share Class	n/a
Shares Outstanding	n/a
Shares Change (YoY)	-1.88%
Shares Change (QoQ)	-0.19%
Owned by Insiders (%)	0.22%
Owned by Institutions (%)	90.48%
Float	574.77M

Valuation Ratios

The trailing PE ratio is 41.50 and the forward PE ratio is 26.91.

PE Ratio	41.50
Forward PE	26.91
PS Ratio	7.22
PB Ratio	4.40
P/TBV Ratio	6.11
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	38.41
EV / Sales	6.97
EV / EBITDA	23.09
EV / EBIT	25.20
EV / FCF	n/a

Financial Position

Current Ratio	n/a
Quick Ratio	n/a
Debt / Equity	0.07
Debt / EBITDA	0.37
Debt / FCF	n/a
Interest Coverage	85.43

Financial Efficiency

Return on Equity (ROE)	n/a
Return on Assets (ROA)	n/a
Return on Invested Capital (ROIC)	21.14%
Return on Capital Employed (ROCE)	n/a
Weighted Average Cost of Capital (WACC)	9.34%
Revenue Per Employee	2.06M
Profits Per Employee	357,411
Employee Count	16,000
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

In the past 12 months, BVMF:E1WL34 has paid 1.17 billion in taxes.

Income Tax	1.17B
Effective Tax Rate	17.33%

Stock Price Statistics

The stock price has decreased by -1.57% in the last 52 weeks. The beta is 0.95, so BVMF:E1WL34's price volatility has been similar to the market average.

Beta (5Y)	0.95
52-Week Price Change	-1.57%
50-Day Moving Average	105.23
200-Day Moving Average	107.70
Relative Strength Index (RSI)	46.61
Average Volume (20 Days)	634

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	1.82

Income Statement

In the last 12 months, BVMF:E1WL34 had revenue of BRL 32.88 billion and earned 5.72 billion in profits. Earnings per share was 9.81.

Revenue	32.88B
Gross Profit	25.61B
Operating Income	9.09B
Pretax Income	6.77B
Net Income	5.72B
EBITDA	9.92B
EBIT	9.09B
Earnings Per Share (EPS)	9.81

Balance Sheet

The company has 22.05 billion in cash and 3.68 billion in debt, giving a net cash position of 18.40 billion.

Cash & Cash Equivalents	22.05B
Total Debt	3.68B
Net Cash	18.40B
Net Cash Per Share	n/a
Equity (Book Value)	53.93B
Book Value Per Share	92.87
Working Capital	n/a

Cash Flow

Operating Cash Flow	n/a
Capital Expenditures	n/a
Depreciation & Amortization	795.08M
Net Borrowing	n/a
Free Cash Flow	n/a
FCF Per Share	n/a

Margins

Gross margin is 77.87%, with operating and profit margins of 27.65% and 17.39%.

Gross Margin	77.87%
Operating Margin	27.65%
Pretax Margin	20.59%
Profit Margin	17.39%
EBITDA Margin	30.17%
EBIT Margin	27.65%
FCF Margin	n/a

Dividends & Yields

BVMF:E1WL34 does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	1.88%
Shareholder Yield	1.88%
Earnings Yield	2.41%
FCF Yield	n/a

Stock Splits

The last stock split was on June 1, 2020. It was a forward split with a ratio of 3.

Last Split Date	Jun 1, 2020
Split Type	Forward
Split Ratio	3

Scores

Altman Z-Score	n/a
Piotroski F-Score	1